FDA approves drug to counter effect of blood thinner Pradaxa
The drug is the first to reverse the effects of the blood-thinning drug Pradaxa to lower the risk of excessive bleeding during surgery.
Modern Healthcare Breaking News
More From Around the Web
Check out these Articles
- 23andMe escapes California class action for arbitration
- Providers turn to technology to match patients to clinical trials
- What’s on the GOP’s Obamacare checklist?
- White House funds ways to treat and identify heroin epidemic
- 2 dead in Florida hospital shooting; suspect captured
- Alabama Medicaid budget shortfall risks losing patients, doctors and waiver
- Medicare payments don't reflect actual uncompensated-care costs
- Molina Healthcare’s stock rises on rosy second quarter
- HCA unnerves investors with healthcare reform outlook
- U.S., Canada issue ransomware warning for hospitals after three hit in a we...
- Tenn. Blues withdrawing from ACA exchanges in Nashville, Memphis and Knoxvi...
- Former state official joins KentuckyOne Health
- Planned Parenthood sues over Ohio law that strips funding
- Doctor fired back at gunman in Pa. hospital attack
- Lupin looks to brands, new markets for growth
- BREAKING: Sweeping Medicaid rule targets enrollment boom in private plans
- CMS and AHIP’s quest to tame the wilds of healthcare quality measures
- Hawaii bill would make doctors treat Medicare patients
- Medical liability premiums flat as California battles over caps
- The Economy of Pot